CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Thailand

GlobalData, the industry analysis specialist, has released its latest report: “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Thailand”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Thailand. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts. In 2015, the population of Thailand 68.84 million, and it is estimated to reach 69.31 million by 2020. The value of the pharmaceutical market was estimated at $5.91 billion in 2015, and is expected to reach $9.47 billion in 2020, increasing at a projected CAGR of 10%. The positive trends in the healthcare market of Thailand can be attributed primarily to: • Increasing medical tourism • Increasing health awareness • Greater access to life-saving facilities

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Thailand, and includes:

An overview of the pharmaceutical and medical device markets, including size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets. The key players covered for the pharmaceutical market are GlaxoSmithKline (GSK), Sanofi, Roche, AstraZeneca and Novartis.

An insightful review of the reimbursement and regulatory landscape, with details of the reimbursement process, regulatory agencies, and market authorization processes for new drug and medical devices

Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure, and healthcare expenditures

An overview of the opportunities and challenges for growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving Thailand’s healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Thailand’s healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance

Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table of Contents

1Table of Contents

1.1List of Tables

1.2List of Figures

2Introduction

2.1GlobalData Report Guidance

3Executive Summary

4Overview of the Pharmaceutical and Medical Device ...

1Table of Contents

1.1List of Tables

1.2List of Figures

2Introduction

2.1GlobalData Report Guidance

3Executive Summary

4Overview of the Pharmaceutical and Medical Device Markets

4.1Pharmaceutical Market

4.1.1Market Overview

4.1.2Pharmaceutical Imports and Exports

4.1.3Supply Channels

4.1.4Market Segments

4.1.5Major Therapeutic Areas

4.1.6Major Companies

4.2Medical Device Market

4.2.1Market Overview

4.2.2Overview of Top Five Segments

4.2.3Major Players

4.3Market Drivers and Barriers

4.3.1Drivers

4.3.2Barriers

5Market Access

5.1Reimbursement and Payer Landscape

5.1.1Healthcare System

5.1.2Reimbursement Process

5.1.3Overview of Insurance Providers

5.1.4Patient Share in Healthcare Spending

5.1.5Pricing Policies

5.2Regulatory Landscape

5.2.1Overview of Regulatory Agencies

5.2.2Drug Approval Process

5.2.3New Device Approval Process

5.2.4Licensing Process for Manufacturing

5.2.5Licensing Process for Exports and Imports

5.2.6Intellectual Property Rights Landscape

5.2.7Clinical Trial Regulations

5.2.8Pharmaceutical Advertising Regulations

5.2.9Pharmacy Regulations

5.2.10Labeling and Packing Regulations

6Country Analysis

6.1Political Environment

6.1.1Political Structure

6.1.2Domestic Political Situation

6.1.3Analysis of the Current Political Environment

6.1.4Healthcare Policy Initiatives

6.2Economic Landscape

6.3Economic Indicators

6.3.1Gross Domestic Product

6.3.2Gross National Income

6.3.3Inflation

6.3.4Currency Exchange Rate

6.3.5Foreign Direct Investment

6.3.6Foreign Exchange Reserves

6.3.7Trade Balance

6.3.8Government Structural Balance

6.3.9Government Net Debt

6.3.10Gross Debt

6.3.11Major Industries

6.4Demographics

6.4.1Population

6.4.2Education and Literacy

6.4.3Employment

6.4.4Disease Burden

6.5Healthcare Infrastructure

6.5.1Healthcare Facilities

6.5.2Healthcare Infrastructure

6.5.3Healthcare Parameters

6.5.4Environmental Health

6.5.5Healthcare Personnel

6.6Healthcare Expenditure

6.6.1Overview

6.6.2Major Components of Healthcare Spending

6.6.3Shares of the Public and Private Sectors

6.6.4Spending in Pharmaceutical R&D

6.7Trade Associations

6.7.1Thai Pharmaceutical Manufacturers Association

6.7.2Thai Medical Technology Industry Association

6.7.3Thai Self-Medication Industry Association

6.7.4The Medical Association of Thailand

6.8Trade Fairs

7Opportunities and Challenges

7.1Opportunities

7.2Challenges

8Appendix

8.1Abbreviations

8.2Bibliography

8.3Research Methodology

8.3.1Coverage

8.3.2Secondary Research

8.3.3Forecasts

8.3.4Expert Panel

8.4Contact Us

8.5Disclaimer

List of Tables

Table 1: Pharmaceutical Market, Thailand, Revenue ($bn), 2008–2015

Table 2: Pharmaceutical Market, Thailand, Revenue ($bn), 2016–2020

Table 3: Pharmaceutical Imports and Exports, Thailand ...

Table 1: Pharmaceutical Market, Thailand, Revenue ($bn), 2008–2015

Table 2: Pharmaceutical Market, Thailand, Revenue ($bn), 2016–2020

Table 3: Pharmaceutical Imports and Exports, Thailand, Revenue ($bn), 2008–2015

Table 4: Pharmaceutical Market, Thailand, Pharmaceutical Product Sales by Segment (%), 2015

Table 5: Pharmaceutical Market, Thailand, Major Therapeutic Areas, Prevalence (%), 2010

Table 6: Major Products, GSK, Global, 2015

Table 7: Late-Stage Pipeline, GSK, Global, 2015

Table 8: Major Products, Sanofi, Global, 2015

Table 9: Late-Stage Pipeline, Sanofi, Global, 2015

Table 10: Major Products, Roche, Global, 2015

Table 11: Late-Stage Pipeline, Roche, Global, 2016

Table 12: Major Products, AstraZeneca, Global, 2016

Table 13: Planned Filings, AstraZeneca, Global, 2016

Table 14: Major Products, Novartis, Global, 2016

Table 15: Late-Stage Pipeline, Novartis, Global, 2015

Table 16: Medical Device Market, Thailand, Revenue ($bn), 2008-2015

Table 17: Medical Device Market, Thailand, Revenue Forecast ($bn), 2016-2020

Table 18: Public Health Insurance Schemes, Thailand, 2016

Table 19: Health Benefits Coverage, Thailand, 2011

Table 20: Market Access, Thailand, Patient Share of Total Health Expenditure (%), 2008–2015

Table 21: Market Access, Thailand, Producer Price Change (%), 2008–2015

Table 22: Economic Indicators, Thailand, Gross Domestic Product per Capita ($), 2008–2015

Table 23: Economic Indicators, Thailand, Gross Domestic Product per Capita ($), 2016–2020

Table 24: Economic Indicators, Thailand, Gross Domestic Product Annual Growth (%), 2008–2015

Table 25: Economic Indicators, Thailand, Gross Domestic Product Annual Growth (%), 2016–2020

Table 26: Economic Indicators, Thailand, Gross National Income per Capita ($), 2008–2014

Table 27: Economic Indicators, Thailand, Consumer Price Index, 2008–2015

Table 28: Economic Indicators, Thailand, Consumer Price Index, 2016–2020

Table 29: Economic Indicators, Thailand, Average Consumer Price Annual Change (%), 2008–2015

Table 30: Economic Indicators, Thailand, Average Consumer Price Annual Change (%), 2016–2020

Table 31: Economic Indicators, Thailand, Currency Exchange Rate (THB/$), 2008–2015

Table 32: Economic Indicators, Thailand, Foreign Direct Investment ($bn), 2008–2014

Table 33: Economic Indicators, Thailand, Foreign Exchange Reserves ($bn), 2008–2014

Table 34: Economic Indicators, Thailand, Imports of Goods and Services ($bn), 2008–2014

Table 35: Economic Indicators, Thailand, Exports of Goods and Services ($bn), 2008–2014

Table 36: Economic Indicators, Thailand, Government Structural Balance ($bn), 2008–2015

Table 37: Economic Indicators, Thailand, General Government Net Debt (% of GDP), 2008–2015

Table 38: Economic Indicators, Thailand, General Government Net Debt, (% of GDP), 2016–2020

Table 39: Major Industries, Thailand, Share of GDP at Current Market Prices (%), 2014

Table 40: Demographics, Thailand, Population (million), 2008–2015

Table 41: Demographics, Thailand, Population (million), 2016–2020

Table 42: Demographics, Thailand, Population, Urban and Rural Population Share (%), 2008–2015

Table 43: Demographics, Thailand, Population, Urban and Rural Population Share (%), 2016–2020

Table 44: Demographics, Thailand, Population Distribution (%), 2006–2011

Table 45: Demographics, Thailand, Population Distribution (%), 2016–2020

Table 46: Demographics, Thailand, Births (per 1,000 population), 2008–2015

Table 47: Demographics, Thailand, Mortality (per 1,000 population), 2008–2015

Table 48: Demographics, Thailand, Major Causes of Mortality (Share %), 2014

Table 49: Demographics, Thailand, Children Under Five Years of Age, Mortality (per 1,000 live births), 2008–2015

Table 50: Demographics, Thailand, Immunization Rate (%), 2008–2015

Table 51: Demographics, Thailand, Major Causes of Male Mortality (Share %), 2010

Table 52: Demographics, Thailand, Major Causes of Female Mortality (Share %), 2010

Table 53: Demographics, Thailand, Gender Ratio (M/F), 2008–2015

Table 54: Demographics, Thailand, Life Expectancy at Birth (years), 2008–2015

Table 55: Demographics, Thailand, Life Expectancy at Birth (Years), 2016–2020

Table 56: Demographics, Thailand, Gross Enrollment Ratio (%), 2008–2015

Table 57: Demographics, Thailand, Unemployment Rate (%), 2008–2015

Table 58: Demographics, Major Diseases, Thailand, DALYs, 2009

Table 59: Healthcare Infrastructure, Thailand, Hospitals, 2008–2015

Table 60: Healthcare Infrastructure, Thailand, Public and Private Hospitals, 2008–2015

Table 61: Healthcare Infrastructure, Thailand, Hospitals by Standard of Care, Share (%), 2010

Table 62: Healthcare Infrastructure, Thailand, Hospital Beds by Authority and Region, Share (%), 2010

Table 63: Healthcare Infrastructure, Thailand, Hospital Beds (per 1,000 population), 2008–2015

Table 64: Healthcare Infrastructure, Thailand, Doctors (per 1,000 Population), 2008–2015

Table 65: Healthcare Infrastructure, Thailand, PM2.5 emissions (µgm/m³), 2008–2015

Table 66: Healthcare Infrastructure, Thailand, CO2 Emissions (Metric Tons Per Capita), 2008–2015

Table 67: Healthcare Infrastructure, Thailand, Dentists (per 100,000 population), 2008–2015

Table 68: Healthcare Infrastructure, Thailand, Nurses (per 100,000 population), 2008–2015

Table 69: Healthcare Infrastructure, Thailand, Pharmacists (per 100,000 population), 2008–2015

Table 70: Healthcare Expenditure (% of GDP), Thailand, 2008–2015

Table 71: Healthcare Expenditure, Thailand, Major Components of Healthcare Expenditure (%), 2012

Table 72: Healthcare Expenditure, Thailand, Public and Private Shares of GDP (%), 2008–2015

Table 73: Healthcare Expenditure, Thailand, R&D Expenditure (% of GDP), 2008-2015

Table 74: Healthcare Expenditure, Thailand, Major Healthcare Trade Fairs, 2017

List of Figures

Figure 1: Pharmaceutical Market, Thailand, Revenue ($bn), 2008-2020

Figure 2: Medical Device Market, Thailand, Revenue ($bn), 2008–2020

Figure 3: Country Profile, Thailand, 2016

Figure ...

Figure 1: Pharmaceutical Market, Thailand, Revenue ($bn), 2008-2020

Figure 2: Medical Device Market, Thailand, Revenue ($bn), 2008–2020

Figure 3: Country Profile, Thailand, 2016

Figure 4: Pharmaceutical Market, Thailand, Revenue ($bn), 2008–2015

Figure 5: Pharmaceutical Market, Thailand, Revenue ($bn), 2016–2020

Figure 6: Pharmaceutical Imports and Exports, Thailand, Revenue ($bn), 2008–2015

Figure 7: Pharmaceutical Industry, Thailand, Structure, 2016

Figure 8: Pharmaceutical Market, Thailand, Pharmaceutical Product Sales by Segment (%), 2015

Figure 9: Pharmaceutical Market, Thailand, Major Therapeutic Areas, Prevalence (%), 2010

Figure 10: Medical Device Market, Thailand, Revenue ($bn), 2008–2015

Figure 11: Medical Device Market, Thailand, Revenue ($bn), 2016–2020

Figure 12: Drivers and Barriers, Healthcare Market, Thailand, 2016

Figure 13: Reimbursement Fund Flow, Thailand, 2016

Figure 14: Health Insurance Development, Thailand, 2016

Figure 15: Addition to National List of Essential Drugs, Thailand, 2016

Figure 16: Drug Procurement Process, Thailand, 2016

Figure 17: Health Benefits Coverage, Thailand, 2011

Figure 18: Market Access, Thailand, Patient Share of Total Health Expenditure (%), 2008–2015

Figure 19: Market Access, Thailand, Producer Price Change (%), 2008–2015

Figure 20: Food and Drug Administration, Thailand, Structure, 2016

Figure 21: Marketing Authorization Procedure, New Drugs, Thailand, 2016

Figure 22: Marketing Authorization Procedure, Generics, Thailand, 2016

Figure 23: Marketing Authorization Procedure, New Generic Drugs, Thailand, 2016

Figure 24: Import Licensing Process for General Medical Device, Thailand, 2016

Figure 25: Patent Approval Process, Thailand, 2016

Figure 26: Trademark Approval Process, Thailand, 2016

Figure 27: Clinical Trial Regulation Process, Thailand, 2016

Figure 28: Economic Indicators, Thailand, Gross Domestic Product per Capita ($), 2008–2015

Figure 29: Economic Indicators, Thailand, Gross Domestic Product per Capita ($), 2016–2020

Figure 30: Economic Indicators, Thailand, Gross Domestic Product Annual Growth (%), 2008–2015

Figure 31: Economic Indicators, Thailand, Gross Domestic Product Annual Growth (%), 2016–2020

Figure 32: Economic Indicators, Thailand, Gross National Income per Capita ($), 2008–2015

Figure 33: Economic Indicators, Thailand, Consumer Price Index, 2008–2015

Figure 34: Economic Indicators, Thailand, Consumer Price Index, 2016–2020

Figure 35: Economic Indicators, Thailand, Average Consumer Price Annual Change (%), 2008–2015

Figure 36: Economic Indicators, Thailand, Average Consumer Price Annual Change (%), 2016–2020

Figure 37: Economic Indicators, Thailand, Currency Exchange Rate (THB/$), 2008–2015

Figure 38: Economic Indicators, Thailand, Foreign Direct Investment ($bn), 2008–2014

Figure 39: Economic Indicators, Thailand, Foreign Exchange Reserves ($bn), 2008–2014

Figure 40: Economic Indicators, Thailand, Imports of Goods and Services ($bn), 2008–2014

Figure 41: Economic Indicators, Thailand, Exports of Goods and Services ($bn), 2008–2014

Figure 42: Economic Indicators, Thailand, Government Structural Balance ($bn), 2008–2015

Figure 43: Economic Indicators, Thailand, General Government Net Debt (% of GDP), 2008–2015

Figure 44: Economic Indicators, Thailand, General Government Net Debt (% of GDP), 2016–2020

Figure 45: Major Industries, Thailand, Share of GDP at Current Market Prices (%), 2014

Figure 46: Demographics, Thailand, Population (million), 2008–2015

Figure 47: Demographics, Thailand, Population (million), 2016–2020

Figure 48: Demographics, Thailand, Population, Urban and Rural Population Share (%), 2008–2015

Figure 49: Demographics, Thailand, Population, Urban and Rural Population Share (%), 2016–2020

Figure 50: Demographics, Thailand, Population Distribution (%), 2008–2015

Figure 51: Demographics, Thailand, Population Distribution (%), 2016–2020

Figure 52: Demographics, Thailand, Births (per 1,000 population), 2008–2015

Figure 53: Demographics, Thailand, Mortality (per 1,000 population), 2008–2015

Figure 54: Demographics, Thailand, Major Causes of Mortality (Share %), 2014

Figure 55: Demographics, Thailand, Children Under Five Years of Age, Infant Mortality (per 1,000 live births), 2008–2015

Figure 56: Demographics, Thailand, Immunization Rate (%), 2008–2015

Figure 57: Demographics, Thailand, Major Causes of Male Mortality (Share %), 2010

Figure 58: Demographics, Thailand, Major Causes of Female Mortality (Share %), 2010

Figure 59: Demographics, Thailand, Gender Ratio (M/F), 2008–2015

Figure 60: Demographics, Thailand, Life Expectancy at Birth (years), 2008–2015

Figure 61: Demographics, Thailand, Life Expectancy at Birth (Years), 2016–2020

Figure 62: Demographics, Thailand, Gross Enrollment Ratio (%), 2008–2015

Figure 63: Demographics, Thailand, Unemployment Rate (%), 2008–2015

Figure 64: Demographics, Major Diseases, Thailand, DALYs, 2012

Figure 65: Healthcare Infrastructure, Thailand, Hospitals, 2008–2015

Figure 66: Healthcare Infrastructure, Thailand, Public and Private Hospitals, 2008–2015

Figure 67: Healthcare Infrastructure, Thailand, Hospitals by Standard of Care, Share (%), 2010

Figure 68: Healthcare Infrastructure, Thailand, Hospital Beds by Authority and Region, Share (%), 2010

Figure 69: Healthcare Infrastructure, Thailand, Hospital Beds (per 1,000 population), 2008–2015

Figure 70: Healthcare Infrastructure, Thailand, Doctors (per 1,000 population), 2008–2015

Figure 71: Healthcare Infrastructure, Thailand, PM2.5 emissions (µgm/m³), 2008–2015

Figure 72: Healthcare Infrastructure, Thailand, CO2 Emissions (Metric Tons Per Capita), 2008–2015

Figure 73: Healthcare Infrastructure, Thailand, Dentists (per 100,000 population), 2008–2015

Figure 74: Healthcare Infrastructure, Thailand, Nurses (per 100,000 population), 2008–2015

Figure 75: Healthcare Infrastructure, Thailand, Pharmacists (per 100,000 population), 2008–2015

Figure 76: Healthcare Expenditure (% of GDP), Thailand, 2008–2015

Figure 77: Healthcare Expenditure, Thailand, Major Components of Healthcare Expenditure (%), 2012

Figure 78: Healthcare Expenditure, Thailand, Public and Private Shares of GDP (%), 2008–2015

Figure 79: Healthcare Expenditure, Thailand, R&D Expenditure (% of GDP), 2008–2015

Figure 80: Healthcare Market, Thailand, Opportunities and Challenges, 2016

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports

GlobalData takes it to the next level and gets into the nitty gritty even in complex diseases

  DRI Capital